Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PARK2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PARK2 is a gene implicated in neurodegeneration research. Key relationships include: associated with, inhibits, activates. Associated with ALS, Aging, Als. Connected to 270 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | PARK2 |
| Full Name | Parkin |
| Chromosome | 6q26 |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | 52 kDa |
| Amino Acids | 465 aa |
| Exons | 12 |
| Pathways | Apoptosis, Immune Response, Mitophagy |
| Ensembl ID | ENSG00000185345 |
| GeneCards | PARK2 |
| Human Protein Atlas | PARK2 |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer's disease, Cancer |
| Known Drugs/Compounds | levodopa, THSG |
| Interactions | AGING, ALS, AND, APOPTOSIS, AR, ATG5 |
| KG Connections | 478 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
PARK2["PARK2
(Parkin Gene)"]
PARKIN["PARKIN
(E3 Ubiquitin Ligase)"]
THSG["THSG
(Therapeutic Compound)"]
Mitophagy["Mitophagy
(Mitochondrial Clearance)"]
Autophagy["Autophagy
(Cellular Clearance)"]
MAP1LC3B["MAP1LC3B
(LC3B)"]
SQSTM1["SQSTM1
(p62)"]
DamagedMito["Damaged
Mitochondria"]
Parkinson["Parkinson's
Disease"]
Neurodegeneration["Neurodegeneration"]
ALS["Amyotrophic Lateral
Sclerosis (ALS)"]
MS["Multiple
Sclerosis"]
Aging["Aging"]
THSG -->|"activates"| PARK2
PARK2 -->|"encodes"| PARKIN
PARK2 -->|"regulates"| Mitophagy
PARK2 -->|"activates"| Autophagy
PARK2 -->|"activates"| MAP1LC3B
PARK2 -->|"associated_with"| SQSTM1
PARKIN -->|"ubiquitinates"| DamagedMito
DamagedMito -->|"cleared_by"| Mitophagy
MAP1LC3B -->|"facilitates"| Autophagy
SQSTM1 -->|"links_to"| Autophagy
PARK2 -->|"inhibits"| Parkinson
PARK2 -->|"inhibits"| Neurodegeneration
PARK2 -->|"regulates"| ALS
PARK2 -->|"inhibits"| MS
PARK2 -->|"inhibits"| Aging
style PARK2 fill:#006494
style PARKIN fill:#4a1a6b
style THSG fill:#1b5e20
style Mitophagy fill:#1b5e20
style Autophagy fill:#1b5e20
style MAP1LC3B fill:#4a1a6b
style SQSTM1 fill:#4a1a6b
style DamagedMito fill:#ef5350
style Parkinson fill:#5d4400
style Neurodegeneration fill:#5d4400
style ALS fill:#5d4400
style MS fill:#5d4400
style Aging fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Mitophagy | mediates | process | 0.95 |
| Parkinson's Disease | risk_factor_for | disease | 0.95 |
| PINK1 | phosphorylates | gene | 0.90 |
| neurodegeneration | associated_with | disease | 0.90 |
| Mitophagy | associated_with | process | 0.90 |
| PRKN | associated_with | gene | 0.90 |
| Substantia Nigra Neurodegeneration | protects_against | phenotype | 0.88 |
| Als | associated_with | disease | 0.85 |
| Parkinson | associated_with | disease | 0.85 |
| SNCA | regulates | gene | 0.80 |
| Parkinson's disease | implicated_in | disease | 0.80 |
| Alzheimer's disease | implicated_in | disease | 0.80 |
| Mitophagy | activates | pathway | 0.80 |
| Aging | inhibits | disease | 0.75 |
| Parkinson | inhibits | disease | 0.75 |
| Mitophagy | inhibits | pathway | 0.70 |
| Parkinson's disease | interacts_with | disease | 0.70 |
| Apoptosis | associated_with | pathway | 0.70 |
| Autophagy | associated_with | pathway | 0.70 |
| SQSTM1 | associated_with | gene | 0.70 |
| PARKIN | activates | gene | 0.70 |
| PARKIN | encodes | protein | 0.70 |
| AUTOPHAGY | associated_with | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| mitophagy | promotes | process | 0.70 |
| UBIQUITIN | associated_with | gene | 0.70 |
| mitophagy | regulates | process | 0.70 |
| PARKIN | associated_with | gene | 0.70 |
| PARKINSON | inhibits | gene | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| PARKINSON'S DISEASE | inhibits | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| PARKINSON | associated_with | gene | 0.70 |
| Als | inhibits | disease | 0.65 |
| Ischemia | associated_with | disease | 0.65 |
| Parkinson | causes | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Cardiovascular | inhibits | disease | 0.65 |
| Melanoma | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Neurodegeneration | causes | disease | 0.65 |
| Heart Failure | inhibits | disease | 0.65 |
| Cardiovascular | degrades | disease | 0.65 |
| Aging | degrades | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-a11f71b5 | targets | hypothesis | 0.90 |
| PINK1 | phosphorylates | gene | 0.90 |
| MANF | binds | protein | 0.80 |
| MIDN | regulates | gene | 0.80 |
| MIF | inhibits | protein | 0.80 |
| GPCPD1 | regulates | gene | 0.80 |
| MITOPHAGY | activates | gene | 0.80 |
| PINK1 | activates | gene | 0.80 |
| THSG | activates | drug | 0.70 |
| MITOPHAGY | inhibits | gene | 0.70 |
| PINK1 | associated_with | gene | 0.70 |
| TP53 | associated_with | gene | 0.60 |
| PINK1 | inhibits | gene | 0.60 |
| ERK1 | associated_with | gene | 0.60 |
| ATXN2 | interacts_with | gene | 0.60 |
| levodopa | targets | drug | 0.60 |
| ATXN2 | causes | gene | 0.60 |
| ATXN2 | activates | gene | 0.60 |
| ATXN2 | regulates | gene | 0.60 |
| NFKB | associated_with | gene | 0.60 |
| AGING | inhibits | gene | 0.60 |
| PARKINSON'S DISEASE | inhibits | gene | 0.60 |
| NEURODEGENERATION | inhibits | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| ATP13A2 | associated_with | gene | 0.60 |
| PARK7 | associated_with | gene | 0.60 |
| MAP1LC3B | interacts_with | entity | 0.60 |
| SNCA | associated_with | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| APOPTOSIS | associated_with | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| MITOCHONDRIA | activates | gene | 0.60 |
| NIX | associated_with | gene | 0.60 |
| MITOPHAGY | degrades | gene | 0.60 |
| AGING | degrades | gene | 0.60 |
| GFP | associated_with | gene | 0.60 |
| MITOCHONDRIA | associated_with | gene | 0.60 |
| BRAIN INJURY | degrades | gene | 0.60 |
| ROS | associated_with | gene | 0.60 |
| PARK1 | expressed_in | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| ALZHEIMER DISEASE | associated_with | gene | 0.60 |
| mitophagy | regulates | pathway | 0.60 |
| BNIP3 | activates | gene | 0.60 |
| PARKIN | associated_with | gene | 0.60 |
| BCL2L13 | associated_with | gene | 0.60 |
| TOMM20 | associated_with | gene | 0.60 |
| ATG7 | associated_with | gene | 0.60 |
| GAPDH | associated_with | gene | 0.60 |
| MAP1LC3B | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| PINK1/PARK2-Mediated Mitophagy Enhancement for Neuroinflamma | 0.571 | neuroinflammation | Immune atlas neuroinflammation analysis |
| PINK1/PARK2-LC3 Mitophagy Enhancement | 0.485 | neuroinflammation | Immune atlas neuroinflammation analysis |
| PINK1/PARK2 Mitophagy Enhancement for Microglial Polarizatio | 0.380 | neuroinflammation | Immune atlas neuroinflammation analysis |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PARK2 in their description or question text
No additional research found